Brief: PolyPid Announces Publication Of Phase 2 Clinical Trial Post-HOC Analysis For D-Plex₁₀₀
Jan 3 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID ANNOUNCES PUBLICATION IN THE AMERICAN JOURNAL OF
SURGERY
OF PHASE 2 CLINICAL TRIAL POST-HOC ANALYSIS FOR D-PLEX₁₀₀ IN THE
PREVENTION OF SURGICAL SITE INFECTIONS IN ABDOMINAL SURGERY
* POLYPID LTD - STUDY RESULTS CONSISTENT WITH SHIELD I PHASE
3
POST-HOC ANALYSIS
Source text for Eikon: ID:nGNXchhnXf
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA